Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1985 Aug 17;291(6493):448. doi: 10.1136/bmj.291.6493.448

Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects.

R J Polson, A Jawed, A Bomford, H Berry, R Williams
PMCID: PMC1416290  PMID: 3926233

Full text

PDF

Page 448

448

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bentley D. P., Williams P. Serum ferritin concentration as an index of storage iron in rheumatoid arthritis. J Clin Pathol. 1974 Oct;27(10):786–788. doi: 10.1136/jcp.27.10.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blake D. R., Hall N. D., Bacon P. A., Dieppe P. A., Halliwell B., Gutteridge J. M. The importance of iron in rheumatoid disease. Lancet. 1981 Nov 21;2(8256):1142–1144. doi: 10.1016/s0140-6736(81)90590-0. [DOI] [PubMed] [Google Scholar]
  3. Bowern N., Ramshaw I. A., Clark I. A., Doherty P. C. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med. 1984 Nov 1;160(5):1532–1543. doi: 10.1084/jem.160.5.1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Frytak S., Moertel C. G. Management of nausea and vomiting in the cancer patient. JAMA. 1981 Jan 23;245(4):393–396. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES